NCT05752565View on ClinicalTrials.gov

Physical Activity and FVIII Elimination: Relevance to Personalized Therapy in Severe Hemophilia A

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

December 30, 2020

Study Completion Date

December 30, 2020

Conditions

Hemophilia A

Interventions

DEVICE

SenseWear armband device

"Device: SenseWear armband device Metabolic Holter, Physical Activity and Lifestyle, Portable outpatient multi-sensor energy consumption in calories (EE), movement, physical activity, quality of life"

Trial Locations (1)

00168

FPG, Roma

All Listed Sponsors

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT05752565 - Physical Activity and FVIII Elimination: Relevance to Personalized Therapy in Severe Hemophilia A | Biotech Hunter | Biotech Hunter